title: Discovery of ixabepilone.
abstract: The discovery of the antineoplastic agent paclitaxel and its unique activity as a microtubule-stabilizing agent resulted in dramatic improvements in the treatment of breast, ovarian, and non-small cell lung cancers. Despite the potent antitumor activity of taxanes such as paclitaxel, efficacy of these agents has been limited by development of taxane-resistant tumors in patients. This review describes, with some historical context, our successful efforts to discover a next-generation microtubule-stabilizing agent for the treatment of cancer. In collaboration with the Gesellschaft für Biotechnologische Forschung, we evaluated the epothilones, originally isolated from the myxobacterium Sorangium cellulosum, as potential anticancer agents. Experiments performed at Bristol-Myers Squibb confirmed the ability of these agents to induce tubulin polymerization, cell cycle arrest, and apoptosis. Epothilones A and B showed potent cytotoxic activity toward paclitaxel-sensitive and paclitaxel-resistant cells expressing P-glycoprotein or mutant tubulin. Because the parent epothilones were subject to inactivation via esterase cleavage, we used semisynthetic approaches to prepare analogues without this liability. BMS-247550 (ixabepilone), the lactam analogue of epothilone B, showed increased metabolic stability, potent tubulin polymerization activity, and retained activity against paclitaxel-resistant lines. Based on its shown efficacy in clinical trials, ixabepilone was approved by the Food and Drug Administration in 2007 for treatment of drug-resistant/refractory metastatic or locally advanced breast cancer.
authors.affiliation: Oncology Drug Discovery, Bristol-Myers Squibb Research and Development, Princeton, NJ 08543-4000, USA. john.hunt@bms.com
authors.forename: John T
authors.initials: JT
authors.lastname: Hunt
mesh_terms: D000818:Animals; D001688:Biological Products / Q000737:chemistry / Q000494:pharmacology; D055808:Drug Discovery / Q000266:history*; D004355:Drug Stability; D034261:Epothilones / Q000737:chemistry / Q000266:history* / Q000494:pharmacology*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007769:Lactams / Q000737:chemistry
chemical_list: D001688:Biological Products; D034261:Epothilones; D007769:Lactams; C430592:ixabepilone